@prefix p: <http://www.wikidata.org/prop/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema1: <http://schema.org/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix wd: <http://www.wikidata.org/entity/> .
@prefix wds: <http://www.wikidata.org/entity/statement/> .
@prefix wdt: <http://www.wikidata.org/prop/direct/> .
@prefix wdtn: <http://www.wikidata.org/prop/direct-normalized/> .
@prefix wikibase: <http://wikiba.se/ontology#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

wd:Q412765 rdfs:label "باليفيزوماب"@ar,
        "Palivizumab"@de,
        "palivizumab"@en,
        "Palivizumab"@es,
        "palivizumab"@fr,
        "Palivizumab"@id,
        "Palivizumab"@it,
        "パリビズマブ"@ja,
        "palivizumab"@nl,
        "palivizumab"@nn,
        "ପାଲିଭିଜୁମାବ"@or,
        "Palivizumab"@pt,
        "Palivizumab"@sh,
        "palivizumab"@sl,
        "Palivizumab"@sr,
        "палівізумаб"@uk,
        "Palivizumab"@vi,
        "帕利珠單抗"@zh,
        "帕利珠单抗"@zh-hans ;
    schema1:dateModified "2026-11-04T17:28:29+00:00"^^xsd:dateTime ;
    schema1:description "chemiese verbinding"@af,
        "compuesto quimico"@an,
        "مركب كيميائي"@ar,
        "compuestu químicu"@ast,
        "রাসায়নিক যৌগ"@bn,
        "compost químic"@ca,
        "chemická sloučenina"@cs,
        "kemisk forbindelse"@da,
        "Protein"@de,
        "chemische Verbindung"@de-ch,
        "pharmaceutical drug"@en,
        "chemical compound"@en-ca,
        "chemical compound"@en-gb,
        "kemia kombinaĵo"@eo,
        "compuesto químico"@es,
        "konposatu kimiko"@eu,
        "kemiallinen yhdiste"@fi,
        "protéine"@fr,
        "composto químico"@gl,
        "תרכובת"@he,
        "քիմիական միացություն"@hy,
        "senyawa kimia"@id,
        "farmaco"@it,
        "کیٖمیٲیی مُرَکَب"@ks,
        "compositum chemicum"@la,
        "cheemesch Verbindung"@lb,
        "ķīmisks savienojums"@lv,
        "kjemisk forbindelse"@nb,
        "chemische verbinding"@nl,
        "kjemisk sambinding"@nn,
        "component quimic"@oc,
        "ଏହା ଏକ ଔଷଧ ଯାହା ଅଧିକ ବିପଦ ଥିବା ଲୋକଙ୍କଠାରେ ଗମ୍ଭୀର ଶ୍ୱାସକ୍ରିୟା ସିନ୍ସିଟିଆଲ୍ ଜୀବାଣୁ ଆରଏସଭି ସଂକ୍ରମଣକୁ ରୋକିବା ପାଇଁ ବ୍ୟବହୃତ ହୁଏ ।"@or,
        "związek chemiczny"@pl,
        "medicamento"@pt,
        "composto químico"@pt-br,
        "compus chimic"@ro,
        "chemická zlúčenina"@sk,
        "protein; biološko zdravilo"@sl,
        "proteinë"@sq ;
    schema1:version 2564773559 ;
    wikibase:identifiers 19 ;
    wikibase:sitelinks 15 ;
    wikibase:statements 31 ;
    skos:altLabel "MEDI-493"@en,
        "Synagis Abbosynagis"@en,
        "anti-RSV"@en,
        "ସିନେଜିସ"@or,
        "帕利珠单抗"@zh ;
    p:P10245 wds:Q412765-6ae3461a-4f59-b6af-1779-aafaea58473c ;
    p:P10283 wds:Q412765-DE988453-A3CB-455A-B37D-6577F9C14DB6 ;
    p:P11143 wds:Q412765-25A9E04E-900B-4780-BB9C-A15023B00FB1 ;
    p:P1552 wds:Q412765-3557A320-AF5C-49F8-B30E-BAFE1930F4A3 ;
    p:P2062 wds:Q412765-29D5F1F7-CDEB-4E01-B57E-5E5E5E78846B ;
    p:P2115 wds:Q412765-1AEB8F6B-6BEC-4074-ACD7-6EEA7BFB5009 ;
    p:P2175 wds:Q412765-0E8E8512-D6AF-4BA5-8AAB-885EEED002A8,
        wds:Q412765-A317A5CF-A702-47D8-B871-05E08B3165BD,
        wds:Q412765-E02C28BA-B9FB-45A6-B0D3-095347BCD4A6,
        wds:Q412765-FAD8658A-7E5C-4986-8BC9-0B438B037757 ;
    p:P2275 wds:Q412765-06155805-D7F9-40E9-9419-A7D7B3AB5E80 ;
    p:P231 wds:Q412765-9078A7DC-7DF9-4CDD-AB85-820A4D5268F4 ;
    p:P267 wds:Q412765-5643D8CF-E557-4BBD-A2A8-B6A303BAD23C ;
    p:P279 wds:Q412765-2218F826-89FE-43F0-BF06-2FDB172F3738 ;
    p:P2868 wds:Q412765-7442AF7E-FE7F-4CF8-AE31-DE437B6FF08F,
        wds:Q412765-C8BC033B-8D20-49BB-9424-DD71A886E75E ;
    p:P31 wds:Q412765-615B61FB-7D8B-4813-8458-FD368AB70DF1 ;
    p:P3345 wds:Q412765-F2A75C2A-453C-447A-BDC1-AA3BC88684DB ;
    p:P366 wds:Q412765-9DB708FB-7E55-4D51-9C15-B627D1D2E1CB ;
    p:P3780 wds:Q412765-F0FE377A-F800-470C-BEA2-208F985D6A5C ;
    p:P4527 wds:Q412765-E4D84E90-F300-4F3A-AEAB-EC60D3F5688D ;
    p:P486 wds:Q412765-C521500F-6BCA-47E3-B4A8-4F6EF13A1D11 ;
    p:P592 wds:Q412765-67B7DA61-D6B5-4CE9-8BF4-6972154CBE66 ;
    p:P6366 wds:Q412765-6B16A3A4-1867-4349-B267-AEA8F2B34620 ;
    p:P646 wds:Q412765-0E2F4D7A-EB9F-4FBF-A9ED-0B9BA8B82787 ;
    p:P652 wds:Q412765-B4EA9C9A-113F-4B1C-9727-300F80DBD5EC ;
    p:P672 wds:Q412765-00095ea4-4ce9-a2fd-efec-876a6bb1d5ab,
        wds:Q412765-4b805f1a-4bc1-eaf2-1581-16a08ba31002,
        wds:Q412765-7b6f8459-40de-18bf-a685-f056ed2ee319 ;
    p:P715 wds:Q412765-4BE3810A-4329-4A3F-8672-5765C66BFA66 ;
    p:P9272 wds:Q412765-036DE8E2-D764-42BE-A683-23D9455C3DCF ;
    wdtn:P2115 <http://purl.bioontology.org/ontology/NDFRT/N0000148570> ;
    wdtn:P4527 <http://data.parliament.uk/terms/428922> ;
    wdtn:P486 <http://id.nlm.nih.gov/mesh/D000069455> ;
    wdtn:P592 <http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL1201586> ;
    wdtn:P6366 <https://makg.org/entity/2778644256> ;
    wdtn:P672 <http://id.nlm.nih.gov/mesh/D12.776.124.486.485.114.224.060.860>,
        <http://id.nlm.nih.gov/mesh/D12.776.124.790.651.114.224.060.860>,
        <http://id.nlm.nih.gov/mesh/D12.776.377.715.548.114.224.200.860> ;
    wdt:P10245 "a698034" ;
    wdt:P10283 "C2778644256" ;
    wdt:P11143 "Palivizumab" ;
    wdt:P1552 wd:Q679692 ;
    wdt:P2062 "8178" ;
    wdt:P2115 "N0000148570" ;
    wdt:P2175 wd:Q18554367,
        wd:Q190805,
        wd:Q3392853,
        wd:Q922640 ;
    wdt:P2275 "palivizumab"@en ;
    wdt:P231 "188039-54-5" ;
    wdt:P267 "J06BB16" ;
    wdt:P279 wd:Q11173 ;
    wdt:P2868 wd:Q40207875,
        wd:Q422248 ;
    wdt:P31 wd:Q113145171 ;
    wdt:P3345 "194279" ;
    wdt:P366 wd:Q12140 ;
    wdt:P3780 wd:Q29006521 ;
    wdt:P4527 "428922" ;
    wdt:P486 "D000069455" ;
    wdt:P592 "CHEMBL1201586" ;
    wdt:P6366 "2778644256" ;
    wdt:P646 "/m/0gdn5s" ;
    wdt:P652 "DQ448MW7KS" ;
    wdt:P672 "D12.776.124.486.485.114.224.060.860",
        "D12.776.124.790.651.114.224.060.860",
        "D12.776.377.715.548.114.224.200.860" ;
    wdt:P715 "DB00110" ;
    wdt:P9272 "55978" .